Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

The GOG 3026 trial demonstrated that ribociclib and letrozole combination therapy achieved a 31% response rate and 84% ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...

Researchers in Class of 1942 Professor of Chemistry Matthew D. Shoulders ' lab have uncovered a sinister hidden mechanism ...

Scientists have recently shed some light on exactly why elephants, one of the biggest animals on the planet, paradoxically experience unusually low rates of cancer. The research found these remarkable ...

Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively ...

In China, physicians are studying an AI tool named PANDA that helps detect early indicators of pancreatic cancer in regular, low-radiation CT scans—before symptoms arise. There are reports of patients ...

The Eve appeal in partnership with North West Cancer Research, has awarded a third Fellowship to Dr Sarah Kitson, gynaecological cancer surgeon and researcher at the University of Manchester.Her three ...